NICE has cleared the way for bevacizumab to be used by the NHS to treat colorectal cancer for the first time, thanks to the availability of lower-cost biosimilar versions of the drug. In recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback